Celldex Therapeutics Inc (CLDX)
Gross Profit Growth
56.71%
TTM · Period ending:
CLDX Gross Profit Growth
Year-over-year change vs the same period a year earlier
Latest reported56.71%period ending
Latest reported56.71%period ending
CLDX TTM Gross Profit YoY % (336.36% → 56.71%)
Year-over-year change
High-resolution chart · PNG
CLDX gross profit growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Gross Profit Growth |
|---|---|
| 122.7734% | |
| 23.1552% | |
| -33.866% | |
| -66.6938% | |
| -57.7906% | |
| -21.7154% | |
| -15.5269% | |
| 68.4211% | |
| 113.3333% | |
| 36.8421% | |
| 62.5% | |
| 26.6667% | |
| -6.25% | |
| 72.7273% | |
| 23.0769% | |
| -11.7647% | |
| -11.1111% | |
| -52.1739% | |
| -53.5714% | |
| -39.2857% | |
| -50% | |
| -50% | |
| -50.8772% | |
| -58.209% | |
| -50.6849% | |
| -41.0256% | |
| -25.974% | |
| -23.8636% | |
| -18.8889% | |
| -12.3596% | |
| -10.2041% | |
| 7.1429% | |
| 14.1026% | |
| 36.1111% | |
| 2.439% | |
| -13.3333% | |
| -23.7624% | |
| -34.5455% | |
| -25.4545% | |
| -17.4312% | |
| 1% | |
| 26.4368% | |
| 34.1463% | |
| 39.7436% | |
| 58.7302% | |
| 47.4576% | |
| 57.6923% | |
| 73.3333% | |
| 61.5385% | |
| 84.375% | |
| 100% | |
| 150% | |
| 3,800% | |
| 633.3333% | |
| 336.3636% |